We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
As a shareholder-friendly measure, Lam Research Corporation (LRCX - Free Report) recently announced a hike in dividend payout. The move indicates the company’s sound financial position and intention to utilize free cash for enhancing its shareholders’ returns.
The company raised quarterly dividend by 4.5% to $1.15 per share from $1.10. This new dividend, approved by its board of directors, will be paid on Oct 16, 2019 to stockholders of record as of Oct 1.
Shares of Lam Research have returned 24.9% over a year against the industry’s 1.9% decline.
We believe that portfolio strength, robust liquidity, strong balance sheet and cash flow generation ability will support its shareholder-friendly initiatives. This will help the stock to sustain momentum in the remainder of fiscal 2019 and beyond.
Impressive Fundamentals Drive Growth
Lam Research topped the Zacks Consensus Estimate in all the trailing four quarters, with an average of 6.52%.
In the last reported quarter, the company reported non-GAAP earnings of $3.62 per share, which outpaced the Zacks Consensus Estimate by 22 cents. Further, revenues of 2.36 billion surpassed the Zacks Consensus Estimate by 0.47%.
Management remains positive about both etch and deposition technologies, which will likely continue to expand its presence in the serviceable addressable market.
Moreover, rising adoption of 3D architectures continues to drive the performance of non-memory segments. Further, advanced packaging technology inflections are acting as tailwinds.
Moreover, aggressive share buyback will fuel the bottom line. The company expects non-GAAP earnings for the fiscal first quarter to be $3.00 (+/- 20 cents) per share and revenues to be $2.15 billion (+/- $150 million).
In the last reported quarter, cash and cash equivalents, short-term investments, as well as restricted cash and investment balance were $5.4 billion, down from $6.1 billion in the fiscal third quarter.
Moreover, Lam Research generated $880.5 million cash from operations in the last reported quarter. The company also paid $164.9 million in cash dividends.
Long-term earnings growth for Alphabet, Itron and Teradyne is currently projected at 17.5%, 25% and 11.4%, respectively.
Legalizing THIS Could Be Even Bigger than Marijuana
Americans spend an estimated $150 billion in this industry every year… more than twice as much as they spend on marijuana.
Now that 8 states have fully-legalized it (with several more states following close behind), Zacks has identified 5 stocks that could soar in response to the powerful demand. One industry insider described the future as “mind-blowing” – and early investors can still get in ahead of the surge.
Image: Bigstock
Lam Research's 4.5% Dividend Hike Boosts Shareholder Return
As a shareholder-friendly measure, Lam Research Corporation (LRCX - Free Report) recently announced a hike in dividend payout. The move indicates the company’s sound financial position and intention to utilize free cash for enhancing its shareholders’ returns.
The company raised quarterly dividend by 4.5% to $1.15 per share from $1.10. This new dividend, approved by its board of directors, will be paid on Oct 16, 2019 to stockholders of record as of Oct 1.
Shares of Lam Research have returned 24.9% over a year against the industry’s 1.9% decline.
We believe that portfolio strength, robust liquidity, strong balance sheet and cash flow generation ability will support its shareholder-friendly initiatives. This will help the stock to sustain momentum in the remainder of fiscal 2019 and beyond.
Impressive Fundamentals Drive Growth
Lam Research topped the Zacks Consensus Estimate in all the trailing four quarters, with an average of 6.52%.
In the last reported quarter, the company reported non-GAAP earnings of $3.62 per share, which outpaced the Zacks Consensus Estimate by 22 cents. Further, revenues of 2.36 billion surpassed the Zacks Consensus Estimate by 0.47%.
Management remains positive about both etch and deposition technologies, which will likely continue to expand its presence in the serviceable addressable market.
Moreover, rising adoption of 3D architectures continues to drive the performance of non-memory segments. Further, advanced packaging technology inflections are acting as tailwinds.
Moreover, aggressive share buyback will fuel the bottom line. The company expects non-GAAP earnings for the fiscal first quarter to be $3.00 (+/- 20 cents) per share and revenues to be $2.15 billion (+/- $150 million).
Lam Research Corporation Price and Consensus
Lam Research Corporation price-consensus-chart | Lam Research Corporation Quote
Cash Flow Generation Remains Strong
In the last reported quarter, cash and cash equivalents, short-term investments, as well as restricted cash and investment balance were $5.4 billion, down from $6.1 billion in the fiscal third quarter.
Moreover, Lam Research generated $880.5 million cash from operations in the last reported quarter. The company also paid $164.9 million in cash dividends.
Zacks Rank & Stocks to Consider
Currently, Lam Research has a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader technology sector include Alphabet Inc. (GOOGL - Free Report) , Itron, Inc. (ITRI - Free Report) and Teradyne, Inc. (TER - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Long-term earnings growth for Alphabet, Itron and Teradyne is currently projected at 17.5%, 25% and 11.4%, respectively.
Legalizing THIS Could Be Even Bigger than Marijuana
Americans spend an estimated $150 billion in this industry every year… more than twice as much as they spend on marijuana.
Now that 8 states have fully-legalized it (with several more states following close behind), Zacks has identified 5 stocks that could soar in response to the powerful demand. One industry insider described the future as “mind-blowing” – and early investors can still get in ahead of the surge.
See these 5 “sin stocks” now >>